What are the clinical manifestations, recommended management, and zoonotic risk of Shamonda virus infection in livestock and humans?

Shamonda virus (SHAV): clinical features, management, and zoonotic risk

Bold recommendation: Treat suspected Shamonda virus outbreaks in livestock as a vector-borne Simbu serogroup orthobunyavirus event with immediate vector control, herd-level testing (RT‑PCR/serology), gestation risk counseling, and supportive care; human disease is unproven and appears minimal, so prioritize occupational precautions over clinical interventions. 1, 2, 3, 4, 5

What to expect clinically

• Livestock (ruminants)

  • Adult cattle: acute fever, diarrhea, lethargy, sharp drop in milk yield during outbreaks; likely Culicoides-borne introduction; consider SHAV when Simbu viruses circulate or SBV differentials are excluded 4.
  • Reproductive/teratogenic disease: abortions, stillbirths, congenital malformations after transplacental infection (analogous to related Simbu viruses; SHAV detected in an aborted goat fetus) 1.
  • Neurologic disease: primarily described with related Simbu viruses; SHAV itself less documented but reassortants within Simbu group can carry neurotropism 5.

• Vectors and ecology

  • Culicoides biting midges implicated; SHAV isolated from Culicoides and sentinel cattle; geographic range wider than historically assumed (Africa, Japan resurgence, Europe emergence) 3, 4.
  • High reassortment potential with Sathuperi/Shuni/Caimito/Sango segments (L/M/S), facilitating phenotype shifts (e.g., virulence, tropism); reassortment more efficient in mammalian cells than insect cells 2, 5.
  • Cross-border spread likely; coordinate surveillance 4.

• Humans

  • Zoonotic illness from SHAV is not established; current evidence does not document confirmed human disease from SHAV specifically. Maintain vigilance due to Simbu group diversity and reassortment capacity 5.
  • General zoonotic risk from animal contact at birthing and vector exposure is recognized in guidelines, but SHAV-specific human morbidity/mortality signal is absent; prioritize exposure reduction rather than treatment frameworks 6, 7.

Immediate management algorithm (prioritizing morbidity, mortality, and quality of life)

1. Identify and confirm at herd level

• Test acutely affected livestock:
  • RT‑PCR targeting Simbu serogroup S segment; if positive, sequence S/M/L to speciate and detect reassortants 1, 2, 5.
  • Use metagenomic sequencing in cluster outbreaks with atypical signs or negative routine panels 4.
• Case definition for high suspicion:
  • Clustered fever/diarrhea/milk-drop in vector season/location with Simbu activity OR abortions/stillbirths/malformations in late gestation 4, 1.

1. Mitigate transmission and fetal loss

• Vector control now:
  • Stable animals during peak midge activity (dusk–dawn), insecticide-impregnated pour-ons, fans, screens, drainage of breeding sites; coordinate farm-perimeter measures 3, 4.
• Gestation risk counseling:
  • Highest fetal risk with maternal infection in early–mid gestation (by Simbu analogs); where feasible, reduce midge exposure of pregnant stock; defer elective breeding during intense vector activity if local transmission is confirmed 1.
• Movement and biosecurity:
  • Restrict movement of clinically affected animals; quarantine newly affected groups; clean equipment; manage waste from aborted materials with PPE and disposal per local regulations [consistent with public-setting zoonosis guidance; apply by analogy] 6, 7.

1. Clinical care of animals

• Supportive only (no approved antivirals or SHAV vaccines):
  • Fluids, NSAIDs as appropriate; manage secondary bacterial complications; monitor pregnant animals for abortion risk 1.
• Diagnostics for differentials:
  • Co-test for Schmallenberg virus, bluetongue, Q fever, BVDV, Brucella as locally indicated because overlapping syndromes drive morbidity/economic loss 8, 6.

1. Surveillance and reporting

• Notify veterinary public health authorities; submit samples from abortions and acutely ill animals for RT‑PCR and sequencing to detect reassortants; cross-border information sharing if in affected regions 4, 5, 3.

Human health and occupational guidance (zoonotic risk)

• Risk characterization
  • No confirmed SHAV human cases; theoretical risk exists via reassortment within Simbu group. Prioritize prevention rather than medical treatment pathways 5, 2.
• Exposure reduction (highest-yield actions)
  • Vector avoidance for workers (repellents, protective clothing at dusk–dawn).
  • Strict PPE (gloves, eye/face protection) when handling birthing materials/aborted fetuses; prompt disposal and disinfection. This aligns with established guidance to prevent zoonoses from reproductive materials at livestock settings and has proven morbidity/mortality benefits for other pathogens (e.g., Q fever) 7, 6, 9.
• Clinical management in exposed humans
  • No SHAV-specific diagnostics or treatment recommended; if a febrile illness occurs after heavy vector exposure in SHAV-affected herds, manage per local arboviral/zoonotic fever protocols and notify public health for investigational testing if available [general arbovirus guidance framework; apply prudently].

Nuances, pitfalls, and how to avoid them

• Pitfall: Assuming single-virus stability. Reality: High reassortment within Simbu viruses can rapidly alter virulence or tropism; always sequence multiple segments when possible 2, 5.
• Pitfall: Overlooking reproductive impact when acute signs wane. Action: Continue monitoring pregnancies for weeks after herd illness; submit aborted materials promptly to confirm etiology and inform control 1.
• Pitfall: Neglecting vector seasonality. Action: Sustain control through the entire vector season; indoor housing plus physical barriers can meaningfully reduce attack rates and protect pregnant stock 3.
• Pitfall: Overinterpreting human risk. Action: Communicate that SHAV human disease is unproven while strictly enforcing occupational PPE around birthing materials per established zoonosis prevention guidance; this protects morbidity and QOL without undue alarm 7, 6.

Decision anchors (when resources are limited)

• If one test: RT‑PCR for Simbu S segment on pooled abortion/blood samples from acutely affected animals; sequence positives 1.
• If one intervention: Dusk–dawn Culicoides control plus indoor housing for pregnant animals during peak vector activity to reduce fetal loss and economic/quality-of-life impacts 3, 4.
• If one message to staff: Use PPE for all contact with birthing/abortion materials; treat as potentially zoonotic per public-setting animal-contact guidance to minimize severe outcomes from known zoonoses while SHAV risk is assessed 7, 6.

Evidence notes

• Highest-quality, most recent, directly relevant data for SHAV in livestock morbidity and reproductive loss come from 2023–2026 molecular detections and outbreak genomics, including an aborted goat fetus (South Africa) and a dairy cattle outbreak (France), and documented reassortants in vectors/animals 1, 4, 5. These guide the firm recommendations above.
• Public health guidance on zoonotic risk from livestock birthing materials and animal-contact settings consistently supports PPE and exposure controls that reduce morbidity and mortality for established pathogens; applied here for precaution given SHAV’s uncertain human pathogenicity 7, 6.